Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EpiCept accelerates clinical trials of EPC-2407 in cancer

July 5, 2007

Algeta initiates clinical dosimetry study with Alpharadin in HRPC patients

July 5, 2007

Mitochondrial voltage-dependent anion channels appear as new targets in cancer therapy

July 5, 2007

New therapeutic agents for cancer covered in recent patent literature

July 5, 2007

New data support role of Velcade in front-line multiple myeloma treatment

July 4, 2007

Phase I data indicate activity of Quadramet in multiple myeloma

July 4, 2007

Newly identified frog-derived ribonuclease could be a future cancer therapy

July 4, 2007

New data indicate activity of perifosine in multiple myeloma

July 4, 2007

Cylene Pharmaceuticals initiates phase II trial of Quarfloxin for cancer

July 4, 2007

Phase II findings warrant advancement of ispinesib for breast cancer

July 4, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...